These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 29055529)
21. Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes. Sun Y; Kang L; Li J; Liu H; Wang Y; Wang C; Zou Y J Cell Mol Med; 2016 Oct; 20(10):1945-55. PubMed ID: 27297874 [TBL] [Abstract][Full Text] [Related]
22. Hypoxia driven glycation: Mechanisms and therapeutic opportunities. Khan MI; Rath S; Adhami VM; Mukhtar H Semin Cancer Biol; 2018 Apr; 49():75-82. PubMed ID: 28546110 [TBL] [Abstract][Full Text] [Related]
23. Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer. Rojas A; Añazco C; González I; Araya P Carcinogenesis; 2018 Apr; 39(4):515-521. PubMed ID: 29373651 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease. Prasad K; Tiwari S Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648 [TBL] [Abstract][Full Text] [Related]
25. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat. Son KH; Son M; Ahn H; Oh S; Yum Y; Choi CH; Park KY; Byun K Biochem Biophys Res Commun; 2016 Aug; 477(2):271-6. PubMed ID: 27301641 [TBL] [Abstract][Full Text] [Related]
26. Protective effect of mangiferin on myocardial ischemia-reperfusion injury in streptozotocin-induced diabetic rats: role of AGE-RAGE/MAPK pathways. Suchal K; Malik S; Khan SI; Malhotra RK; Goyal SN; Bhatia J; Kumari S; Ojha S; Arya DS Sci Rep; 2017 Feb; 7():42027. PubMed ID: 28181586 [TBL] [Abstract][Full Text] [Related]
27. Role of advanced glycation end products in diabetic neuropathy. Sugimoto K; Yasujima M; Yagihashi S Curr Pharm Des; 2008; 14(10):953-61. PubMed ID: 18473845 [TBL] [Abstract][Full Text] [Related]
28. Pentoxifylline mitigates renal glycoxidative stress in obese mice by inhibiting AGE/RAGE signaling and increasing glyoxalase levels. Inacio MD; Costa MC; Lima TFO; Figueiredo ID; Motta BP; Spolidorio LC; Assis RP; Brunetti IL; Baviera AM Life Sci; 2020 Oct; 258():118196. PubMed ID: 32763295 [TBL] [Abstract][Full Text] [Related]
29. Advanced glycation end-products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation. Chen YJ; Chan DC; Chiang CK; Wang CC; Yang TH; Lan KC; Chao SC; Tsai KS; Yang RS; Liu SH J Orthop Res; 2016 May; 34(5):791-800. PubMed ID: 26497299 [TBL] [Abstract][Full Text] [Related]
30. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515 [TBL] [Abstract][Full Text] [Related]
31. RAGE: a novel cellular receptor for advanced glycation end products. Schmidt AM; Hori O; Cao R; Yan SD; Brett J; Wautier JL; Ogawa S; Kuwabara K; Matsumoto M; Stern D Diabetes; 1996 Jul; 45 Suppl 3():S77-80. PubMed ID: 8674899 [TBL] [Abstract][Full Text] [Related]
32. Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression. Muthyalaiah YS; Jonnalagadda B; John CM; Arockiasamy S Glycoconj J; 2021 Dec; 38(6):717-734. PubMed ID: 35064413 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of RAGE Axis Signaling: A Pharmacological Challenge. Rojas A; Morales M; Gonzalez I; Araya P Curr Drug Targets; 2019; 20(3):340-346. PubMed ID: 30124149 [TBL] [Abstract][Full Text] [Related]
34. Male infertility: A proximate look at the advanced glycation end products. Omolaoye TS; du Plessis SS Reprod Toxicol; 2020 Apr; 93():169-177. PubMed ID: 32050094 [TBL] [Abstract][Full Text] [Related]
35. Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Thornalley PJ Int Rev Neurobiol; 2002; 50():37-57. PubMed ID: 12198817 [TBL] [Abstract][Full Text] [Related]
36. Advanced glycation end products increased placental vascular permeability of human BeWo cells via RAGE/NF-kB signaling pathway. Shi Y; Qian J; Zhang Q; Hu Y; Sun D; Jiang L Eur J Obstet Gynecol Reprod Biol; 2020 Jul; 250():93-100. PubMed ID: 32413668 [TBL] [Abstract][Full Text] [Related]
37. Glycation & the RAGE axis: targeting signal transduction through DIAPH1. Shekhtman A; Ramasamy R; Schmidt AM Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251 [TBL] [Abstract][Full Text] [Related]
38. Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs. Deluyker D; Evens L; Bito V Amino Acids; 2017 Sep; 49(9):1535-1541. PubMed ID: 28710551 [TBL] [Abstract][Full Text] [Related]
39. The in vivo and in vitro approaches for establishing a link between advanced glycation end products and lung cancer. Khan H; Khan MS; Ahmad S J Cell Biochem; 2018 Nov; 119(11):9099-9109. PubMed ID: 30076739 [TBL] [Abstract][Full Text] [Related]
40. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses. Oczypok EA; Perkins TN; Oury TD Paediatr Respir Rev; 2017 Jun; 23():40-49. PubMed ID: 28416135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]